Auto Added by WPeMatico

expert reaction to phase 2a clinical trial of cannabidiol (CBD) in treating people with cannabis use disorder

A study, published in Lancet Psychiatry,  looked at cannabidiol (CBD) in treating people with cannabis use disorder.   Prof Sir Robin Murray, Professor of Psychiatric Research, Institute of Psychiatry Psychology & Neuroscience, King’s College London (IoPPN), said: “This is an excellent study by well-regarded researchers. “The press release is accurate…

Continue Reading expert reaction to phase 2a clinical trial of cannabidiol (CBD) in treating people with cannabis use disorder

End of content

No more pages to load